In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
14 authors.
Nathan A BraceyDepartment of Medicine; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.ORCID 0000-0001-7938-1691 Casey BepplerInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-9241-2413 Tatjana BilichInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-8107-0419 Adrienne H LongInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-1523-9095 Elsa SolaInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Aviv BarakDepartment of Immunology, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.ORCID 0009-0005-8081-9642 Timothy J Few-CooperDepartment of Immunology, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.ORCID 0009-0009-3775-4547 Azam MohsinInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-0021-3244 Vishnu ShankarInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Vamsee MallajosyulaInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-0658-3652 Lilit KamalyanInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Robson CapassoDivision of Sleep Surgery, Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-2645-1793 Shai S Shen-OrrDepartment of Immunology, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.ORCID 0000-0002-6991-7736 Mark M DavisInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Funding
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5MThe effects of immune-age on immune-response and the molecular mechanisms which drive itP01AI153559 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2021 to 2025
$17.8MCXCL13 as an aging-associated defect in memory T cell homeostasisF32AI186256 · NIAID · STANFORD UNIVERSITY · PI Casey Beppler · 2024 to 2026
$193kNIAID NIH HHS F32 AI186256NIAID NIH HHS P01 AI153559NIAID NIH HHS U19 AI057229
6 · The paper itselfAbstract
A decline in specific antibody responses is a hallmark of human aging, yet the differential contributions of B and T lymphocytes and their interactions remain unclear. CXCL13 is a critical chemokine that shapes germinal center organization, but the regulation of human-specific CXCL13
Indexed as
agingCXCL13gene regulationhuman immunologymaturationTfh cells
Identifiers
PMID41993471
PMCPMC13082170
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390